No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy. Experts weigh in on the path to profit for the treatment and the therapeutic class in general.
Vertex, CRISPR’s Casgevy Faces Complex Path to Profitability Read More »
On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in development, Novo Nordisk showcased more details about its own oral candidate.
Novo’s Obesity Pill Yields ‘Remarkable’ 13% Weight Loss, Investigators Say Read More »
A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, but analysts remain dubious of the estimate.
What Expanded CVD Medicare Coverage May Mean for Novo Nordisk’s Wegovy Read More »
Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms wouldn’t address a dearth of competition in the larger market.
Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.
Bain Raises $3B for Fourth Fund to Back Promising Life Sciences Companies Read More »
The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for patients with type 1 and 2 diabetes, respectively.
Lilly Continues Once-Weekly Insulin Rally With Two Phase III Diabetes Readouts Read More »
A study published Tuesday in The New England Journal of Medicine showed that children between the ages of six and 12 who took liraglutide for just over a year experienced a significant reduction in body mass index compared to placebo.
Novo’s Saxenda Effectively, Safely Lowers BMI in Children: NEJM Study Read More »
Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes simplex virus vaccine after failing to meet the study’s primary efficacy objective.
GSK Abandons Herpes Vaccine After Disappointing Phase I/II Proof-of-Concept Data Read More »
Plus, learn about what to expect in initial interviews and how to time your post-Ph.D. job search for maximum success.
Career Coach: Why Fall Is Prime Time for Your Biotech Job Hunt Read More »
La tecnología de hogar inteligente ha revolucionado la forma en que interactuamos con nuestros espacios, ofreciendo conveniencia, confort y eficiencia energética. Desde asistentes controlados por voz hasta electrodomésticos y sistemas de seguridad conectados, estos dis …
El Futuro de la Tecnología de Hogar Inteligente en Alquileres de Airbnb Read More »
